Managing Board
- Dr Georges Belfort, RPI, Chair
- Evan Flach, AIChE, Executive Director
- Dr Dana Andersen, Denali Therapeutics, Member
- Dr William E Bentley, University of Maryland, Member
- Dr Brian H Davison, Oak Ridge National Laboratory, Member
- Dr Omolola Eniola-Adefeso, University of Michigan, Officer
- Dr Gregory T. Frank, Amgen (Retired), Member
- Dr Michael Jewett, Stanford University, Member
- Dr Karmella Haynes, Emory University
- Dr Kristala Jones-Prather, MIT, Member
- Dr. Jessica Winter, Ohio State University, Officer
- Ms June C. Wispelwey, AIChE (Retired), Member
Advisory Board
- Dr Robert Kelly, North Caroline State University, Chair
- Dr Hal Alper, University of Texas, Austin
- Dr John Aunins, Seres Therapeutics
- Dr Nelson Barton, Genomatica
- Dr Kirsten Benjamin, Pivot Bio
- Dr Douglas Clark, UC Berkeley
- Dr Nancy DaSilva, UC Irvine
- Dr Michael Domach, Carnegie-Mellon University
- Dr Jon Dordick, RPI
- Dr Martin Fussenegger, ETH Zurich Switzerland
- Dr Katie Galloway, MIT
- Dr George Georgiou, University of Texas, Austin
- Dr Amy Johnson, Regeneron
- Dr Hemanth Kaligotla, Lonza
- Dr Mattheos Koffas, RPI
- Dr Aditya Kunjapur, University of Delaware
- Dr Michael Ladisch, Purdue University
- Dr Kelvin Lee, University of Delaware
- Dr Sang Yup Lee, Korea Advanced Institute of Science and Technology
- Dr Costas Maranas, Penn State University
- Robin Ng, Cellular Biomedicine Group
- Dr Eleftherios T. Papoutsakis, University of Delaware
- Vineet Rajagarhia, ErgBio
- Dr Yi Tang, UCLA
- Dr Nigel Titchener-Hooker, University College London
- Dr Jackie Ying, Instute for Bioengineering and Nanotechnology, Singapore